82 related articles for article (PubMed ID: 15223371)
1. Glycosaminoglycan C3 protects against AF64A-induced cholinotoxicity in a dose-dependent and time-dependent manner.
Rose M; Dudas B; Cornelli U; Hanin I
Brain Res; 2004 Jul; 1015(1-2):96-102. PubMed ID: 15223371
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of the heparin-derived oligosaccharide C3, on AF64A-induced cholinergic lesion in rats.
Rose M; Dudas B; Cornelli U; Hanin I
Neurobiol Aging; 2003; 24(3):481-90. PubMed ID: 12600723
[TBL] [Abstract][Full Text] [Related]
3. Low molecular weight glycosaminoglycan C3 attenuates AF64A-stimulated, low-affinity nerve growth factor receptor-immunoreactive axonal varicosities in the rat septum.
Dudas B; Rose M; Cornelli U; Hanin I
Brain Res; 2005 Feb; 1033(1):34-40. PubMed ID: 15680337
[TBL] [Abstract][Full Text] [Related]
4. Effects of repeated administration of (-)-nicotine on AF64A-induced learning and memory impairment in rats.
Hiramatsu M; Yamatsu T; Kameyama T; Nabeshima T
J Neural Transm (Vienna); 2002 Mar; 109(3):361-75. PubMed ID: 11956957
[TBL] [Abstract][Full Text] [Related]
5. Noradrenaline depletion protects cholinergic neurons in rat hippocampus against AF64A-induced damage.
Hörtnagl H; Potter PE; Kindel G; Hanin I
J Neurosci Methods; 1989 Mar; 27(2):103-8. PubMed ID: 2709878
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent effect of cholinotoxin AF64A on the cholinergic elements of the cingulum bundle in rat.
Dudas B; Rose M; Hanin I
Brain Res; 2003 Mar; 965(1-2):295-8. PubMed ID: 12591151
[TBL] [Abstract][Full Text] [Related]
7. Time course of ethylcholine aziridinium ion (AF64A)-induced cholinotoxicity in vivo.
Leventer SM; Wulfert E; Hanin I
Neuropharmacology; 1987 Apr; 26(4):361-5. PubMed ID: 3587537
[TBL] [Abstract][Full Text] [Related]
8. Age-dependent effect of AF64A on cholinergic activity in the septo-hippocampal pathway of the rat brain: decreased responsiveness in aged rats.
El Tamer A; Wülfert E; Hanin I
Neurosci Lett; 1996 Jan; 203(2):123-6. PubMed ID: 8834109
[TBL] [Abstract][Full Text] [Related]
9. Oral and subcutaneous administration of the glycosaminoglycan C3 attenuates Abeta(25-35)-induced abnormal tau protein immunoreactivity in rat brain.
Dudas B; Cornelli U; Lee JM; Hejna MJ; Walzer M; Lorens SA; Mervis RF; Fareed J; Hanin I
Neurobiol Aging; 2002; 23(1):97-104. PubMed ID: 11755024
[TBL] [Abstract][Full Text] [Related]
10. Arecoline via miniosmotic pump improves AF64A-impaired radial maze performance in rats: a possible model of Alzheimer's disease.
Bartolomeo AC; Morris H; Boast CA
Neurobiol Learn Mem; 1997 Nov; 68(3):333-42. PubMed ID: 9398593
[TBL] [Abstract][Full Text] [Related]
11. Protection against inflammatory neurodegeneration and glial cell death by 7beta-hydroxy epiandrosterone, a novel neurosteroid.
Dudas B; Hanin I; Rose M; Wülfert E
Neurobiol Dis; 2004 Mar; 15(2):262-8. PubMed ID: 15006696
[TBL] [Abstract][Full Text] [Related]
12. Reversible cholinergic changes induced by AF64A in rat hippocampus and possible septal compensatory effect.
el Tamer A; Corey J; Wülfert E; Hanin I
Neuropharmacology; 1992 Apr; 31(4):397-402. PubMed ID: 1522957
[TBL] [Abstract][Full Text] [Related]
13. Deficits in cholinergic neurotransmission markers induced by ethylcholine mustard aziridinium (AF64A) in the rat hippocampus: sensitivity to treatment with the monoamine oxidase-B inhibitor L-deprenyl.
Ricci A; Mancini M; Strocchi P; Bongrani S; Bronzetti E
Drugs Exp Clin Res; 1992; 18(5):163-71. PubMed ID: 1490432
[TBL] [Abstract][Full Text] [Related]
14. [Effects of AF64A on neurons containing both nitric oxide synthase and choline acetyltransferase in the rat septal complex].
Yu FL; Shan HY; Dong XW
Sheng Li Xue Bao; 1996 Feb; 48(1):15-22. PubMed ID: 8758685
[TBL] [Abstract][Full Text] [Related]
15. Cholinergic neurotoxicity induced by ethylcholine aziridinium (AF64A) in neuron-enriched cultures.
Davies DL; Sakellaridis N; Valcana T; Vernadakis A
Brain Res; 1986 Jul; 378(2):251-61. PubMed ID: 3730876
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective properties of glycosaminoglycans: potential treatment for neurodegenerative disorders.
Dudas B; Rose M; Cornelli U; Pavlovich A; Hanin I
Neurodegener Dis; 2008; 5(3-4):200-5. PubMed ID: 18322390
[TBL] [Abstract][Full Text] [Related]
17. Low intracerebroventricular doses of cholinotoxin AF64A do not affect the morphology of gonadotropin hormone-releasing hormone (GnRH)-immunoreactive fibers in the rat septum.
Semeniken K; Hanin I; Dudas B
Brain Res; 2005 Jul; 1049(2):240-3. PubMed ID: 15950199
[TBL] [Abstract][Full Text] [Related]
18. Potential animal models for senile dementia of Alzheimer's type, with emphasis on AF64A-induced cholinotoxicity.
Fisher A; Hanin I
Annu Rev Pharmacol Toxicol; 1986; 26():161-81. PubMed ID: 3087271
[TBL] [Abstract][Full Text] [Related]
19. AF64A-induced cytotoxicity and changes in choline acetyltransferase activity in the LA-N-2 neuroblastoma cell line are modulated by choline and hemicholinium-3.
Santiago LR; Ivy MT; Erickson LC; Hanin I
J Neurosci Methods; 1995; 61(1-2):185-90. PubMed ID: 8618417
[TBL] [Abstract][Full Text] [Related]
20. Sector-dependent neurotoxicity of ethylcholine aziridinium (AF64A) in the rat hippocampus.
Laganiere S; Marinko M; Corey J; Wulfert E; Hanin I
Neuropharmacology; 1990 Oct; 29(10):961-4. PubMed ID: 2255388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
